Aspartylglucosaminidase (AGA) (Middle Region) Peptide
AGA
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN972986
Quick Overview for Aspartylglucosaminidase (AGA) (Middle Region) Peptide (ABIN972986)
Target
AGA
(Aspartylglucosaminidase (AGA))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- SMGFINEDLS TTASQALHSD WLARNCQPNY WRNVIPDPSK YCGPYKPPGI
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-AGA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- AGA (Aspartylglucosaminidase (AGA))
-
Background
-
Aspartylglucosaminidase is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. The lysosomal storage disease aspartylglycosaminuria is caused by a deficiency in the AGA enzyme.
Alias Symbols: AGU, ASRG, GA
Protein Interaction Partner: AGA,ALB,IGF2R,AGA
Protein Size: 336 -
Molecular Weight
- 36 kDa
-
Gene ID
- 175
-
NCBI Accession
- NM_001171988, NP_001165459
-
UniProt
- P20933
Target
-
You are here:
